A Direção Geral de Saúde acaba de publicar (março de 2020) um guião com informação útil que pretende esclarecer o cidadão e os profissionais de saúde, sobre o COVID-19. Pode obter essa informação clicando aqui. A Sociedade Portuguesa de Microbiologia fornece outras ligações úteis, com informação generalista e científica sobre este assunto.
Última actualização a 01/05/2022
Páginas específicas em Português sobre o vírus e a pandemia:
- Site da Direção Geral de Saúde
- Portal dos Cientistas Portugueses com ideias colaborativas para combater o COVID-19
- Evidência Médica (resumo em PT de várias fontes de informação científica)
- Centro de informação COVID-19 do Governo de Portugal
- Centro de notícias sobre COVID-19 em Portugal
- Site do Instituto de Higiene e Medicina Tropical
- Site do Instituto Nacional de Saúde Dr. Ricardo Jorge
- Site da Universidade do Minho
- Site da Universidade de Coimbra
- Site da Universidade do Algarve
- National Geographic Portugal
- Fundação Osvaldo Cruz – Brasil
- Diversidade genética do novo coronavirus SARS-Cov-2 em Portugal
- Plataforma Imune.Pt
Informação – especialistas da SPM – COVID-19
- Página pessoal do Virologista Professor Jubilado João Vasconcelos Costa
- Artigo de opinião de Isabel Sá-Correira, presidente da SPM
Páginas específicas (internacionais) sobre o vírus e a pandemia:
- Site do Centro Europeu de Prevenção e Controlo de Doenças (ECDC)
- ECDC immune response to Covid-19
- Site do Centro Norte-Americano de Prevenção e Controlo de Doenças
- Sociedade Americana de Microbiologia (ASM)
- Material didático e informativo da ASM
- National Institutes of Health (NIH)
- Site da Organização Mundial de Saúde
- Universidade de Johns Hopkins mapeamento global
- London School of Hygiene and Tropical Medicine
- Institute Pasteur COVID-19 Resource Center
- Karolinska Institute COVID-19 Resource Center
- Federação Europeia das Sociedades de Microbiologia (FEMS)
- The Lancet Hub – COVID-19 Resource Centre
- Global alliance against chronic respiratory diseases
- Science magazine: Race to find COVID-19 treatments accelerates
- Cambridge University Press COVID-19 free acess collection
- COVID-19 Genomics UK consortium
Alguns artigos científicos relevantes (em inglês)
- A distinct name is needed for the new coronavirus, Jiang, S., Shi, Z., Shu, Y., et al., The Lancet, February 19 (2020),
- A new coronavirus associated with human respiratory disease in China, Wu, F., Zhao, S., Yu, B., et al., Nature 579, 265–269 (2020)
- A pneumonia outbreak associated with a new coronavirus of probable bat origin, Zhou, P., Yang, X., Wang, X., et al., Nature 579, 270–273 (2020)
- Outbreak of a novel coronavirus, Du Toit, A., Nat Rev Microbiol 18, 123 (2020)
- Therapeutic options for the 2019 novel coronavirus (2019-nCoV), Li, G. andDe Clercq, E., Nature Reviews Drug Discovery 19, 149-150 (2020)
- The proximal origin of SARS-CoV-2, KG. Andersen, A Rambaut, WI Lipkin, EC Holmes & RF Garry, Nature Medicine, doi: 10.1038/s41591-020-0820-9
- Human antibodies can neutralize SARS-CoV-2, Catalan-Dibene J, Nature Reviews Immunology volume 20, 350 (2020)
- Respiratory virus shedding in exhaled breath and efficacy of face masks, Leung et al, Nature Medicine 26, 676–680(2020)
- BCG Vaccination Protects against Experimental Viral Infection in Humans through the Induction of Cytokines Associated with Trained Immunity, Arts et al, Cell Host & Microbe 23, 89–100
- Virological assessment of hospitalized patients with COVID-2019, Wolfel et al, Nature 581, 465–469(2020)
- A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. Boulware et al, The New England Journal of Medicine, DOI: 10.1056/NEJMoa2016638
- Waiting for Certainty on Covid-19 Antibody Tests — At What Cost?, Weinstein et al, New England Journal of Medicine, DOI: 10.1056/NEJMp2017739
- Coronavirus Disease 2019 (COVID-19) Re-infection by a Phylogenetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2 Strain Confirmed by Whole Genome Sequencing, To et al (2020), Clinical Infectious Diseases
- SARS-CoV-2 vaccines in development, Krammer (2020), Nature
- The effect of temperature on persistence of SARS‑CoV‑2 on common surfaces, Riddel et al (2020), Virology Journal
- Transmission heterogeneities, kinetics, and controllability of SARS-CoV-2, Sun et al (2020), Science
- Rapid increase of a SARS-CoV-2 variant with multiple spike protein mutations observed in the United Kingdom, ECDC (2020)
- Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine, Sadoff et al (2021), New England Journal of Medicine
- Evolution of antibody immunity to SARS-CoV-2, Gaebler et al (2021), Nature
- Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia, Lugunov et al (2021), The Lancet
- Prospective mapping of viral mutations that escape antibodies used to treat COVID-19, Starr et al (2021), Science
- BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting, Dagan et al (2021), New England Journal of Medicine
- Immunological mechanisms of vaccine-induced protection against COVID-19 in humans (2021), Nature Reviews Immunology
- Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines (2021), New England Journal of Medicine
- SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans (2021), Nature
- SARS-CoV-2 variants, spike mutations and immune escape (2021) Nature Reviews Microbiology
- Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis
- Increased Memory B Cell Potency and Breadth After a SARS-CoV-2 mRNA Boost
Sociedade Portuguesa de Microbiologia 